drugset / Trial / NCT00824811

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

NCT00824811

RandomizedParallel-groupDouble-blindTreatment

Summary

Objective: To evaluate the safety and efficacy of topical cyclosporine eye drops (Restasis®) for the treatment of epiphora caused by canalicular stenosis secondary to Docetaxel (Taxotere®) treatment for various cancers.

Timeline

Start
2009-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Castor Oil Unknown 1 unknown Topical
Subject Cyclosporine Peptide 1 unknown Topical
Background Fluorometholone Other / unclassified 1 unknown

Indications